Page 2 - ஜங் சோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜங் சோய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜங் சோய் Today - Breaking & Trending Today

GBT In-Licenses Two Sickle Cell Small Molecule Programs from Sanofi


Share
Rare Daily Staff
Global Blood Therapeutics entered into an agreement with Sanofi to exclusively in-license worldwide rights to two early-stage research programs in sickle cell disease: one that pursues a novel anti-sickling mechanism and another that leverages a new approach to reduce inflammation and oxidative stress.
These mechanisms are distinct and potentially complementary to that of GBT’s Oxbryta, a novel hemoglobin S polymerization small molecule inhibitor approved in the United States for the treatment of Sickle Cell Disease in patients ages 12 years and older. The programs, from Sanofi’s Bioverativ subsidiary, supplement GBT’s existing pipeline and support the company’s strategy to address SCD from multiple approaches. ....

United States , Jung Choi , Sanofi Bioverativ , Blood Therapeutics , Sickle Cell Disease , South Asian , Southern European , Middle Eastern , ஒன்றுபட்டது மாநிலங்களில் , ஜங் சோய் , இரத்தம் சிகிச்சை , அரிவாள் செல் நோய் , தெற்கு ஆசிய , தெற்கு ஐரோப்பிய , நடுத்தர கிழக்கு ,